{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:53:50Z","timestamp":1772121230174,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015642","name":"Project of Shandong Province Higher Educational Science and Technology Program","doi-asserted-by":"publisher","award":["J18KA176"],"award-info":[{"award-number":["J18KA176"]}],"id":[{"id":"10.13039\/501100015642","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.meegid.2020.104427","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T02:42:51Z","timestamp":1592448171000},"page":"104427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A dose-response study in mice of a tetravalent recombinant dengue envelope domain III protein secreted from insect cells"],"prefix":"10.1016","volume":"85","author":[{"given":"Lijun","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guolei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.meegid.2020.104427_bb0005","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S1473-3099(16)30168-2","article-title":"The risks behind Dengvaxia recommendation","volume":"16","author":"Aguiar","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"8","key":"10.1016\/j.meegid.2020.104427_bb0010","doi-asserted-by":"crossref","first-page":"E830","DOI":"10.1016\/S2214-109X(18)30295-X","article-title":"Dengue vaccine: reliably determining previous exposure","volume":"6","author":"Ari\u00ebn","year":"2018","journal-title":"Lancet Glob. Health"},{"issue":"7446","key":"10.1016\/j.meegid.2020.104427_bb0015","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"issue":"51","key":"10.1016\/j.meegid.2020.104427_bb0020","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.1016\/j.vaccine.2010.10.004","article-title":"A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice","volume":"28","author":"Block","year":"2010","journal-title":"Vaccine."},{"issue":"9951","key":"10.1016\/j.meegid.2020.104427_bb0025","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.meegid.2020.104427_bb0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/dna.2006.0547","article-title":"Induction of tetravalent protective immunity against four dengue serotypes by the tandem domain III of the envelope protein","volume":"26","author":"Chen","year":"2007","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.meegid.2020.104427_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/srep30648","article-title":"Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice","volume":"6","author":"Chiang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.meegid.2020.104427_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micinf.2006.09.009","article-title":"The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry","volume":"9","author":"Chin","year":"2007","journal-title":"Microbes Infect."},{"issue":"50","key":"10.1016\/j.meegid.2020.104427_bb0045","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1016\/j.vaccine.2015.11.023","article-title":"Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies","volume":"34","author":"Coudeville","year":"2016","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.meegid.2020.104427_bb0050","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","article-title":"Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells","volume":"75","author":"Crill","year":"2001","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.meegid.2020.104427_bb0055","first-page":"129","article-title":"Dengue vaccine candidates in development","volume":"338","author":"Durbin","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"6","key":"10.1016\/j.meegid.2020.104427_bb0060","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/jiw067","article-title":"A 12-month\u2013interval dosing study in adults indicates that a single dose of the national institute of allergy and infectious diseases tetravalent dengue vaccine induces a robust neutralizing antibody response","volume":"214","author":"Durbin","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.meegid.2020.104427_bb0065","first-page":"836","article-title":"Dengue virus type-3 envelope protein domain III; expression and immunogenicity","volume":"17","author":"Fahimi","year":"2014","journal-title":"Iranian J. Basic Med. Sci."},{"issue":"7","key":"10.1016\/j.meegid.2020.104427_bb0070","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s00253-018-8822-y","article-title":"Dengue viruses and promising envelope protein domain III-based vaccines","volume":"102","author":"Fahimi","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"6303","key":"10.1016\/j.meegid.2020.104427_bb0075","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1126\/science.aaf9590","article-title":"Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment","volume":"353","author":"Ferguson","year":"2016","journal-title":"Science."},{"issue":"1","key":"10.1016\/j.meegid.2020.104427_bb0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/icb.2014.63","article-title":"The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2","volume":"93","author":"Gil","year":"2015","journal-title":"Immunol. Cell Biol."},{"issue":"6","key":"10.1016\/j.meegid.2020.104427_bb0085","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1038\/cti.2017.24","article-title":"The tetravalent formulation of domain III-capsid proteins recalls memory B-and T-cell responses induced in monkeys by an experimental dengue virus infection","volume":"6","author":"Gil","year":"2017","journal-title":"Clin. Transl. Immunol."},{"issue":"22","key":"10.1016\/j.meegid.2020.104427_bb0090","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1073\/pnas.0703498104","article-title":"Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention","volume":"104","author":"Goncalvez","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"22","key":"10.1016\/j.meegid.2020.104427_bb0095","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1016\/j.vaccine.2011.03.038","article-title":"A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness","volume":"29","author":"Gunther","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.meegid.2020.104427_bb0100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","article-title":"Evaluation of interferences between dengue vaccine serotypes in a monkey model","volume":"80","author":"Guy","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"9966","key":"10.1016\/j.meegid.2020.104427_bb0105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(14)60572-9","article-title":"Dengue","volume":"385","author":"Guzman","year":"2015","journal-title":"Lancet."},{"issue":"12supp","key":"10.1016\/j.meegid.2020.104427_bb0110","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/nrmicro2460","article-title":"Dengue: a continuing global threat","volume":"8","author":"Guzman","year":"2010","journal-title":"Nat. Rev. Microbiol. Nat. Rev. Microbiol."},{"issue":"7","key":"10.1016\/j.meegid.2020.104427_bb0115","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00705-013-1645-3","article-title":"Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection","volume":"158","author":"Guzman","year":"2013","journal-title":"Arch. Virol."},{"issue":"13","key":"10.1016\/j.meegid.2020.104427_bb0120","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9599","key":"10.1016\/j.meegid.2020.104427_bb0125","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.meegid.2020.104427_bb0130","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.vaccine.2016.02.004","article-title":"Protective and immunological behavior of chimeric yellow fever dengue vaccine","volume":"34","author":"Halstead","year":"2016","journal-title":"Vaccine"},{"issue":"122","key":"10.1016\/j.meegid.2020.104427_bb0135","first-page":"24","article-title":"Immunological enhancement of dengue virus replication","volume":"243","author":"Halstead","year":"1973","journal-title":"Nat. New Biol."},{"issue":"10","key":"10.1016\/j.meegid.2020.104427_bb0140","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1473-3099(10)70166-3","article-title":"Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes","volume":"10","author":"Halstead","year":"2010","journal-title":"Lancet Infect. Dis."},{"issue":"11","key":"10.1016\/j.meegid.2020.104427_bb0145","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1128\/CVI.00145-07","article-title":"Single antigen detects both immunoglobulin M (IgM) and IgG antibodies elicited by all four dengue virus serotypes","volume":"14","author":"Hapugoda","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"issue":"16","key":"10.1016\/j.meegid.2020.104427_bb0150","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1016\/j.vaccine.2006.01.036","article-title":"A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates","volume":"24","author":"Hermida","year":"2006","journal-title":"Vaccine."},{"issue":"6","key":"10.1016\/j.meegid.2020.104427_bb0155","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.vaccine.2006.09.059","article-title":"Dengue tetravalent DNA vaccine increases its immunogenicity in mice when mixed with a dengue type 2 subunit vaccine or an inactivated Japanese encephalitis vaccine","volume":"25","author":"Imoto","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.meegid.2020.104427_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003673","article-title":"Functionality of dengue virus specific memory T cell responses in individuals who were hospitalized or who had mild or subclinical dengue infection","volume":"9","author":"Jeewandara","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"23\u201324","key":"10.1016\/j.meegid.2020.104427_bb0165","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/S0264-410X(01)00020-2","article-title":"Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers","volume":"19","author":"Kanesa-thasan","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.meegid.2020.104427_bb0170","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.micinf.2008.12.004","article-title":"A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity","volume":"11","author":"Leng","year":"2009","journal-title":"Microbes Infect."},{"issue":"11","key":"10.1016\/j.meegid.2020.104427_bb0175","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1128\/JCM.40.11.4317-4320.2002","article-title":"Serological differentiation of infections with dengue virus serotypes 1 to 4 by using recombinant antigens","volume":"40","author":"Ludolfs","year":"2002","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"10.1016\/j.meegid.2020.104427_bb0180","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10096-004-1145-1","article-title":"Dengue: an arthropod-borne disease of global importance","volume":"23","author":"Mairuhu","year":"2004","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"30","key":"10.1016\/j.meegid.2020.104427_bb0185","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1016\/j.vaccine.2016.03.108","article-title":"Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold\/DNA vaccine in non-human primates","volume":"34","author":"McBurney","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.meegid.2020.104427_bb0190","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/jcm.22.2.250-254.1985","article-title":"Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization","volume":"22","author":"Morens","year":"1985","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2020.104427_bb0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.virusres.2015.02.008","article-title":"Dengue virus envelope domain III protein based on a tetravalent antigen secreted from insect cells: potential use for serological diagnosis","volume":"201","author":"Niu","year":"2015","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.meegid.2020.104427_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12896-016-0280-y","article-title":"Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies","volume":"16","author":"Poddar","year":"2016","journal-title":"BMC Biotechnol."},{"issue":"23","key":"10.1016\/j.meegid.2020.104427_bb0205","doi-asserted-by":"crossref","first-page":"12561","DOI":"10.1128\/JVI.06743-11","article-title":"Gamma interferon (IFN-\u03b3) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-\u03b1\/\u03b2 receptor-deficient mice","volume":"86","author":"Prestwood","year":"2012","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.meegid.2020.104427_bb0210","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mib.2008.06.004","article-title":"Structural proteomics of dengue virus","volume":"11","author":"Rushika","year":"2008","journal-title":"Curr. Opin. Microbiol."},{"issue":"9853","key":"10.1016\/j.meegid.2020.104427_bb0215","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.meegid.2020.104427_bb0220","doi-asserted-by":"crossref","first-page":"13486","DOI":"10.1128\/JVI.01104-12","article-title":"Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and mammalian cells","volume":"86","author":"Schnettler","year":"2012","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.meegid.2020.104427_bb0225","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1128\/JVI.78.6.2701-2710.2004","article-title":"Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T-and B-cell-dependent immunity are less critical","volume":"78","author":"Shresta","year":"2004","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.meegid.2020.104427_bb0230","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(13)70028-8","article-title":"Dengue vaccine efficacy trial: does interference cause failure?","volume":"13","author":"Swaminathan","year":"2013","journal-title":"Lancet Infect. Dis."},{"issue":"8","key":"10.1016\/j.meegid.2020.104427_bb0235","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1099\/0022-1317-82-8-1885","article-title":"Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism","volume":"82","author":"Thullier","year":"2001","journal-title":"J. Gen. Virol."},{"issue":"8","key":"10.1016\/j.meegid.2020.104427_bb0240","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1007\/s00705-017-3360-y","article-title":"A dose-response study in mice of a tetravalent vaccine candidate composed of domain III-capsid proteins from dengue viruses","volume":"162","author":"Vald\u00e9s","year":"2017","journal-title":"Arch. Virol."},{"issue":"10","key":"10.1016\/j.meegid.2020.104427_bb0245","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/INF.0b013e31829b8022","article-title":"Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9-16 year olds: a randomized, controlled, phase II trial in Latin America","volume":"32","author":"Villar","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"2","key":"10.1016\/j.meegid.2020.104427_bb0250","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.meegid.2020.104427_bb0255","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virol.2009.06.037","article-title":"Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody","volume":"392","author":"Wahala","year":"2009","journal-title":"Virology."},{"issue":"22","key":"10.1016\/j.meegid.2020.104427_bb0260","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.meegid.2020.104427_bb0265","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1128\/JVI.02298-12","article-title":"An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection","volume":"87","author":"White","year":"2013","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.meegid.2020.104427_bb0270","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2012.03.003","article-title":"Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo","volume":"429","author":"Williams","year":"2012","journal-title":"Virology."},{"issue":"28","key":"10.1016\/j.meegid.2020.104427_bb0275","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.vaccine.2009.03.083","article-title":"A simple method for evaluating dengue vaccine effectiveness in mice based on levels of viremia caused by intraperitoneal injection of infected culture cells","volume":"27","author":"Yamanaka","year":"2009","journal-title":"Vaccine"}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134820302586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134820302586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:44:48Z","timestamp":1761576288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134820302586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":55,"alternative-id":["S1567134820302586"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2020.104427","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.20898\/v1","asserted-by":"object"}]},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A dose-response study in mice of a tetravalent recombinant dengue envelope domain III protein secreted from insect cells","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2020.104427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104427"}}